RE:RE:RE:RE:News release timed with AGMSometimes it's better to be lucky than good. Looks like they got lucky with patients 5 and 6 in phase 1b. The patients in phase 2 not so much. I guess that's why they needed more testing before final approval. Unfortunately current shareholders waited patiently for the past year only to have their investment kneecapped by someone's ineptitude. Never mind the phase 2 patients who should all be NIMBC cancer free right now.